Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) EPS (Weighted Average and Diluted) (2020 - 2025)

Rapid Micro Biosystems' EPS (Weighted Average and Diluted) history spans 6 years, with the latest figure at -$0.27 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 22.73% to -$0.27 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.06, a 1.85% increase, with the full-year FY2025 number at -$1.05, up 2.78% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.27 in Q4 2025 for Rapid Micro Biosystems, down from -$0.26 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for RPID hit a ceiling of $1.2 in Q4 2021 and a floor of -$37.89 in Q1 2021.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$3.11 across 5 years, with a median of -$0.31 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 103.25% in 2021 and later tumbled 131.67% in 2022.
  • Tracing RPID's EPS (Weighted Average and Diluted) over 5 years: stood at $1.2 in 2021, then tumbled by 131.67% to -$0.38 in 2022, then soared by 31.58% to -$0.26 in 2023, then increased by 15.38% to -$0.22 in 2024, then dropped by 22.73% to -$0.27 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for RPID at -$0.27 in Q4 2025, -$0.26 in Q3 2025, and -$0.27 in Q2 2025.